Use of specific neuromodulators in the treatment of chronic, idiopathic cough: A systematic review

Otolaryngology - Head and Neck Surgery (United States)

Volumn 148, Issue 3, 2013, Pages 374-382

  Cohen, Seth M ^a   Misono, Stephanie ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Amitriptyline; Baclofen; Chronic cough; Gabapentin; Idiopathic cough; Neuromodulator; Pregabalin; Treatment

Indexed keywords

AMITRIPTYLINE; BACLOFEN; CAPSAICIN; CARBAMAZEPINE; CODEINE; GABAPENTIN; GUAIFENESIN; PLACEBO; PREGABALIN; 4 AMINOBUTYRIC ACID; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; AMINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; DRUG DERIVATIVE;

AMNESIA; ARTICLE; BLURRED VISION; CHRONIC COUGH; CONFUSION; DISEASE DURATION; DISEASE SEVERITY; DIZZINESS; DRUG TREATMENT FAILURE; FATIGUE; FOLLOW UP; HEADACHE; HUMAN; IDIOPATHIC DISEASE; NAUSEA; NONHUMAN; OUTCOME ASSESSMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; STOMACH PAIN; SYSTEMATIC REVIEW; TREATMENT DURATION; XEROSTOMIA; CHRONIC DISEASE; COUGHING; REVIEW;

AMINES; AMITRIPTYLINE; BACLOFEN; CHRONIC DISEASE; COUGH; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; HUMANS; NEUROTRANSMITTER AGENTS; QUALITY OF LIFE;

MLCS; MLOWN;

EID: 84876097487     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599812471817     Document Type: Article

References (35)

1. Barbee RA, Halonen M, Kalktenborn WT, Burrows B. A longitudinal study of respiratory symptoms in a community population sample. Chest. 1991;99:20-26.
2. Centers for Disease Control and Prevention. National Ambulatory Medical Care Survey: 2009 summary tables. www.cdc.gov/nchs/data/ahcd/namcs-summary/2009- namcs-web-tables.pdf. Accessed September 5, 2012.
3. Consumer Healthcare Products Association. OTC sales by category - 2008-2011. http://chpa-info.org/pressroom/Sales-Category. aspx. Accessed September 5, 2012.
4. Brignall K, Jayaraman B, Birring SS. Quality of life and psychosocial aspects of cough. Lung. 2008;371:1364-1374.
5. Raj AA, Birring SS. Clinical assessment of chronic cough severity. Pulm Pharmacol Ther. 2007;20:334-337. (Pubitemid 46518189)
6. Dicpinigaitis PV, Tso R, Banauch G. Prevalence of depressive symptoms among patients with chronic cough. Chest. 2006; 130:1839-1843. (Pubitemid 46033443)
7. McGarvey LPA, Carton C, Gamble LA, et al. Prevalence of psychomorbidity among patients with chronic cough. Cough. 2006;2:4.
8. Pratter MR, Bartter T, Akers S, DuBois J. An algorithmic approach to chronic cough. Ann Intern Med. 1993;119:977-983. (Pubitemid 23334653)
9. Haque Ra, Usmani OS, Barnes PJ. Chronic idiopathic cough: a discrete clinical entity? Chest. 2005;127:1710-1713. (Pubitemid 46218799)
10. Kardos P. Proposals for a rationale and for rational diagnosis of cough. Pneumologie. 2000;54:110-115. (Pubitemid 30223977)
11. Gibson PG, Ryan NM. Cough pharmacotherapy: current and future status. Expert Opin Pharmacother. 2011;12:1745-1755.
12. Norris BK, Schweinfurth JM. Management of recurrent laryngeal sensory neuropathic symptoms. Ann Otol Rhinol Laryngol. 2010;119:188-191.
13. Lee B, Woo P. Chronic cough as a sign of laryngeal sensory neuropathy: diagnosis and treatment. Ann Otol Rhinol Laryngol. 2005;114:253-257. (Pubitemid 40529978)
14. Bastian RW, Vaidya AM, Delsupehe KG. Sensory neuropathic cough: a common and treatable cause of chronic cough. Otolaryngol Head Neck Surg. 2006;135:17-21. (Pubitemid 43946545)
15. Dicpinigaitis PB, Dobkin JB. Antitussive effect of the GABAagonist baclofen. Chest. 1997;111:996-999.
16. Smith SM, Schroeder L, Fahey T. Over the counter medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev. 2012;(8):CD001831.
17. Chang AB, Lasserson TJ, Gaffney J, Connor FL, Garske LA. Gastro-esophageal reflux treatment for prolonged non-specific cough in children and adults. Cochrane Database Syst Rev. 2011;(1):CD004823.
18. Molassiotis A, Bryan G, Caress A, Bailey C, Smith J. Pharamcological and non-pharmacological interventions for cough in adults with respiratory and non-respiratory diseases: a systematic review of the literature. Respir Med. 2010;104:934-944.
19. Halum SL, Sycamore DL, McRae BR. A new treatment option for laryngeal sensory neuropathy. Laryngoscope. 2009;119: 1844-1847.
20. Amin MR, Koufman JA. Vagal neuropathy after upper respiratory infection: a viral etiology? Am J Otolaryngol. 2001;22:251-256. (Pubitemid 32718039)
21. Morrison RJ, Schindler JS. Evaluation and treatment of the patient with chronic cough referred to the otolaryngologist. Laryngoscope. 2011;121(suppl 5):S256.
22. Agostinis P, Bardus P, Di Piazza V. Treatment of recalcitrant cough with baclofen. Italian J Med. 2009;3:172-174.
23. Ryan CM, Birring SS, Gibson PG. Gabapentin for refractory chronic cough: a randomized, double-blind, placebo-controlled trial. Lancet. 2012;380:1583-1589.
24. Jeyakumar A, Brickman TM, Haben M. Effectiveness of amitriptyline versus cough suppressants in the treatment of chronic cough resulting from postviral vagal neuropathy. Laryngoscope. 2006;116:2108-2112. (Pubitemid 44912302)
25. Mintz S, Lee JK. Gabapentin in the treatment of intractable idiopathic chronic cough: case reports. Am J Med. 2006;119: e13-e15.
26. Dicpinigaitis PV, Rauf K. Treatment of chronic, refractory cough with baclofen. Respiration. 1998;65:86-88. (Pubitemid 28076131)
27. Bonham AC, Sekizawa S, Chen CT, Joad JP. Plasticity of brainstem mechanisms of cough. Respir Physiol Neurobiol. 2006;152:312-319. (Pubitemid 44037509)
28. Birring SS. Developing antitussives: the ideal clinical trial. Pulm Pharmacol Ther. 2009;22:155-158.
29. Prudon B, Birring SS, Vara DD, Hall AP, Thompson JP, Pavord ID. Cough and glottis-stop reflex sensitivity in health and disease. Eur Respir J. 2007;29:1256-1276.
30. Birring SS, Fleming T, Matos S, Raj AA, Evans DH, Pavord ID. The Leicester cough monitor: preliminary validation of an automated cough detection system in chronic cough. Eur Respir J. 2008;31:1013-1018.
31. Dicpinigaitis PV, Alva RV. Safety of capsaicin cough challenge testing. Chest. 2005;128:196-202. (Pubitemid 40994473)
32. Birring SS, Matos S, Patel RB, Prudon B, Evans DH, Pavord ID. Cough frequency, cough sensitivity and health status in patients with chronic cough. Respir Med. 2006;10:1105-1109.
33. Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003;58:339-343. (Pubitemid 36411421)
34. Groneberg DA, Niimi A, Dinh QT, et al. Increased expression of transient receptor potential vanilloid-1 in airway nerves in chronic cough. Am J Respir Crit Care Med. 2004;12:1276-1280. (Pubitemid 39657190)
35. Lalloo UG, Fox AJ, Belvisi MG, Chung KF, Barnes PJ. Capsazepine inhibits cough induced by capsaicin and citric acid but not by hypertonic saline in guinea pigs. J Appl Physiol. 1995;79:1082-1087.